165 related articles for article (PubMed ID: 17695461)
1. Dynamics of serum levels of tumour markers and prognosis of recurrence and survival after liver surgery for colorectal liver metastases.
Liska V; Holubec L; Treska V; Skalicky T; Sutnar A; Kormunda S; Pesta M; Finek J; Rousarova M; Topolcan O
Anticancer Res; 2007; 27(4C):2861-4. PubMed ID: 17695461
[TBL] [Abstract][Full Text] [Related]
2. Preoperative tumor markers as prognostic factors of colorectal liver metastases.
Treska V; Topolcan O; Stanislav K; Liska V; Holubec L
Hepatogastroenterology; 2009; 56(90):317-20. PubMed ID: 19579590
[TBL] [Abstract][Full Text] [Related]
3. Tumor markers as useful predictors of survival rate after exploratory laparotomy for liver malignancies.
Liska V; Holubec L; Treska V; Skalicky T; Sutnar A; Topolcan O; Kormunda S; Finek J
Anticancer Res; 2007; 27(4A):1887-91. PubMed ID: 17649789
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
[TBL] [Abstract][Full Text] [Related]
5. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases.
Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR
Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of colorectal liver metastases after surgical treatment: multifactorial study.
Liska V; Treska V; Holubec L; Kormunda S; Skalicky T; Sutnar A; Topolcan O
Hepatogastroenterology; 2007 Sep; 54(78):1741-4. PubMed ID: 18019708
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
8. Low preoperative serum carcinoembryonic antigen concentration is a marker of good prognosis in patients undergoing cryotherapy for low volume hepatic metastases from colorectal cancer.
Seifert JK; Morris DL
Int J Surg Investig; 2000; 2(4):327-34. PubMed ID: 12678536
[TBL] [Abstract][Full Text] [Related]
9. Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity.
Viganò L; Ferrero A; Lo Tesoriere R; Capussotti L
Ann Surg Oncol; 2008 Sep; 15(9):2458-64. PubMed ID: 18463927
[TBL] [Abstract][Full Text] [Related]
10. Recurrence after complete cryoablation of colorectal liver metastases: analysis of prognostic features.
Yan TD; Nunn DR; Morris DL
Am Surg; 2006 May; 72(5):382-90. PubMed ID: 16719189
[TBL] [Abstract][Full Text] [Related]
11. Difference between free circulating plasma and serum DNA in patients with colorectal liver metastases.
Thijssen MA; Swinkels DW; Ruers TJ; de Kok JB
Anticancer Res; 2002; 22(1A):421-5. PubMed ID: 12017326
[TBL] [Abstract][Full Text] [Related]
12. Value of serum carbohydrate antigen 19-9 for predicting extrahepatic metastasis in patients with liver metastasis from colorectal carcinoma.
Sasaki A; Kawano K; Inomata M; Shibata K; Matsumoto T; Kitano S
Hepatogastroenterology; 2005; 52(66):1814-9. PubMed ID: 16334783
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of follow-up after surgical treatment of colorectal liver metastases.
Langenhoff BS; Krabbe PF; Ruers TJ
Eur J Surg Oncol; 2009 Feb; 35(2):180-6. PubMed ID: 18691847
[TBL] [Abstract][Full Text] [Related]
14. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence.
Holubec L; Topolcan O; Pikner R; Pecen L; Vaclavickova J; Wirthova M; Molacek J; Stieber P; Holdenrieder S; Sen LH; Finek J
Anticancer Res; 2000; 20(6D):5237-44. PubMed ID: 11326702
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of colorectal liver metastases - workflow].
Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
[TBL] [Abstract][Full Text] [Related]
17. Indicators of recurrence following cryotherapy for hepatic metastases from colorectal cancer.
Seifert JK; Morris DL
Br J Surg; 1999 Feb; 86(2):234-40. PubMed ID: 10100794
[TBL] [Abstract][Full Text] [Related]
18. Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis.
Katsuno H; Zacharakis E; Aziz O; Rao C; Deeba S; Paraskeva P; Ziprin P; Athanasiou T; Darzi A
Ann Surg Oncol; 2008 Nov; 15(11):3083-91. PubMed ID: 18787906
[TBL] [Abstract][Full Text] [Related]
19. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.
Waas ET; Wobbes T; Ruers T; Lomme RM; Hendriks T
Eur J Surg Oncol; 2006 Sep; 32(7):756-63. PubMed ID: 16650961
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of serum CEA protein and CEA mRNA after resection of colorectal liver metastases.
Kijima M; Togo S; Ichikawa Y; Miura M; Yamagishi S; Matsuo K; Tanaka K; Masui H; Ishikawa T; Ike H; Shimada H
Anticancer Res; 2005; 25(2B):1327-32. PubMed ID: 15865086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]